{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:53:39Z","timestamp":1790992419033,"version":"4.1.0"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05960-z","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:24:09Z","timestamp":1790990649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ciprofloxacin beyond antibacterial therapy: pharmacological mechanisms, anticancer activity, and translational limitations"],"prefix":"10.1007","author":[{"given":"Rezvan","family":"Tahmasbi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Khalaj-Kondori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezu","family":"Karimpur-zahmatkesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,3]]},"reference":[{"issue":"5","key":"5960_CR1","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.21873\/anticanres.14245","volume":"40","author":"R Alaaeldin","year":"2020","unstructured":"Alaaeldin R, Nazmy MH, Abdel-Aziz M, Abuo-Rahma GE-DA, Fathy M (2020) Cell cycle arrest and apoptotic effect of 7-(4-(N-substituted carbamoylmethyl) piperazin-1-yl) ciprofloxacin-derivative on HCT 116 and A549 cancer cells. Anticancer Res 40(5):2739\u20132749. https:\/\/doi.org\/10.21873\/anticanres.14245","journal-title":"Anticancer Res"},{"issue":"5","key":"5960_CR2","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.21873\/anticanres.15013","volume":"41","author":"R Alaaeldin","year":"2021","unstructured":"Alaaeldin R, Abuo-Rahma GE-DA, Zhao Q-L, Fathy M (2021) Modulation of apoptosis and epithelial-mesenchymal transition E-cadherin\/TGF-\u03b2\/Snail\/TWIST pathways by a new ciprofloxacin chalcone in breast cancer cells. Anticancer Res 41(5):2383\u20132395. https:\/\/doi.org\/10.21873\/anticanres.15013","journal-title":"Anticancer Res"},{"issue":"22","key":"5960_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27227993","volume":"27","author":"R Alaaeldin","year":"2022","unstructured":"Alaaeldin R, Abdel-Rahman IM, Ali FE, Bekhit AA, Elhamadany EY, Zhao Q-L et al (2022) Dual topoisomerase I\/II inhibition-induced apoptosis and necro-apoptosis in cancer cells by a novel ciprofloxacin derivative via RIPK1\/RIPK3\/MLKL activation. Molecules 27(22):7993. https:\/\/doi.org\/10.3390\/molecules27227993","journal-title":"Molecules"},{"issue":"1","key":"5960_CR4","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s11033-024-09768-z","volume":"51","author":"M Alhajamee","year":"2024","unstructured":"Alhajamee M, Khalaj-Kondori M, Babaei E, Mahdavi M (2024) A biochemical assessment of apoptosis-inducing impact of salinomycin in combination with ciprofloxacin on human leukemia KG1\u2013a stem-like cells in the presence and absence of insulin. Mol Biol Rep 51(1):807. https:\/\/doi.org\/10.1007\/s11033-024-09768-z","journal-title":"Mol Biol Rep"},{"key":"5960_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122093","volume":"296","author":"SO Alhaj-Suliman","year":"2023","unstructured":"Alhaj-Suliman SO, Naguib YW, Wafa EI, Saha S, Ebeid K, Meng X et al (2023) A ciprofloxacin derivative with four mechanisms of action overcomes paclitaxel resistance in p53-mutant and MDR1 gene-expressing type II human endometrial cancer. Biomaterials 296:122093. https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122093","journal-title":"Biomaterials"},{"key":"5960_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1149809","volume":"14","author":"A Alim Al-Bari","year":"2023","unstructured":"Alim Al-Bari A, Ito Y, Thomes PG, Menon MB, Garc\u00eda-Macia M, Fadel R et al (2023) Emerging mechanistic insights of selective autophagy in hepatic diseases. Front Pharmacol 14:1149809. https:\/\/doi.org\/10.3389\/fphar.2023.1149809","journal-title":"Front Pharmacol"},{"key":"5960_CR7","doi-asserted-by":"publisher","unstructured":"Al-Mahdwi TT, Said AM, Hade IM, Yasin YS, Jumaa AH. Synergistic cytotoxic impact of linagliptin-ciprofloxacin combination on cervical cancer cell line: insights into targeting heat shock protein 60. Asian Pacific Journal of Cancer Prevention: APJCP. 2025;26(6):2117. https:\/\/doi.org\/10.31557\/APJCP.2025.26.6.2117","DOI":"10.31557\/APJCP.2025.26.6.2117"},{"issue":"12","key":"5960_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22592","volume":"9","author":"S Al-Taweel","year":"2023","unstructured":"Al-Taweel S, Al-Saraireh Y, Al-Trawneh S, Alshahateet S, Al-Tarawneh R, Ayed N et al (2023) Synthesis and biological evaluation of ciprofloxacin\u20131, 2, 3-triazole hybrids as antitumor, antibacterial, and antioxidant agents. Heliyon 9(12):e22592. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22592","journal-title":"Heliyon"},{"issue":"1","key":"5960_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s11033-025-10764-0","volume":"52","author":"F Amini","year":"2025","unstructured":"Amini F, Khalaj-Kondori M, Baradaran B (2025) Inhibition of CD133 resulted in cell death, inhibition of angiogenesis, and limited migration in the melanoma cancer cell line. Mol Biol Rep 52(1):659. https:\/\/doi.org\/10.1007\/s11033-025-10764-0","journal-title":"Mol Biol Rep"},{"issue":"8","key":"5960_CR10","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1080\/08820139.2020.1797778","volume":"50","author":"S Assar","year":"2021","unstructured":"Assar S, Nosratabadi R, Khorramdel Azad H, Masoumi J, Mohamadi M, Hassanshahi G (2021) A review of immunomodulatory effects of fluoroquinolones. Immunol Investig 50(8):1007\u20131026. https:\/\/doi.org\/10.1080\/08820139.2020.1797778","journal-title":"Immunol Investig"},{"issue":"1","key":"5960_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202000180","volume":"354","author":"HA Aziz","year":"2021","unstructured":"Aziz HA, Moustafa GA, Abuo-Rahma GEDA, Rabea SM, Hauk G, Krishna VS et al (2021) Synthesis and antimicrobial evaluation of new nitric oxide-donating fluoroquinolone\/oxime hybrids. Arch Pharm 354(1):e2000180. https:\/\/doi.org\/10.1002\/ardp.202000180","journal-title":"Arch Pharm"},{"issue":"3","key":"5960_CR12","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s11030-021-10302-7","volume":"26","author":"HA Aziz","year":"2022","unstructured":"Aziz HA, El-Saghier AM, Badr M, Abuo-Rahma GE-DA, Shoman ME (2022) Thiazolidine-2, 4-dione-linked ciprofloxacin derivatives with broad-spectrum antibacterial, MRSA and topoisomerase inhibitory activities. Mol Divers 26(3):1743\u20131759. https:\/\/doi.org\/10.1007\/s11030-021-10302-7","journal-title":"Mol Divers"},{"issue":"1","key":"5960_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-73793-y","volume":"14","author":"HA Aziz","year":"2024","unstructured":"Aziz HA, El-Saghier AM, Badr M, Elsadek BE, Abuo-Rahma GE-DA, Shoman ME (2024) Design, synthesis and mechanistic study of N-4-piperazinyl butyryl thiazolidinedione derivatives of ciprofloxacin with anticancer activity via topoisomerase I\/II inhibition. Sci Rep 14(1):24101. https:\/\/doi.org\/10.1038\/s41598-024-73793-y","journal-title":"Sci Rep"},{"key":"5960_CR14","doi-asserted-by":"publisher","unstructured":"Banti CN, Kalousi FD, Psarra A-MG, Moushi EE, Leonidas DD, Hadjikakou SK. Silver ciprofloxacin (CIPAG): a multitargeted metallodrug in the development of breast cancer therapy. JBIC Journal of Biological Inorganic Chemistry. 2024;29(2):177\u201386. https:\/\/doi.org\/10.1007\/s00775-024-02048-y","DOI":"10.1007\/s00775-024-02048-y"},{"key":"5960_CR15","doi-asserted-by":"publisher","unstructured":"Barzegari R, Mohammadzadeh M, Mahdavi M. In vitro assessment of novel ciprofloxacin derivative effects on cell proliferation, cell cycle and oxidative stress\u2013induced apoptosis in chronic myeloid leukemia K562 cell line. Journal of Applied Toxicology. 2026:1\u201310. https:\/\/doi.org\/10.1002\/jat.70151","DOI":"10.1002\/jat.70151"},{"key":"5960_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ejphar.2018.08.002","volume":"835","author":"A Beberok","year":"2018","unstructured":"Beberok A, Rzepka Z, Respondek M, Rok J, Sierotowicz D, Wrze\u015bniok D (2018) GSH depletion, mitochondrial membrane breakdown, caspase-3\/7 activation and DNA fragmentation in U87MG glioblastoma cells: new insight into the mechanism of cytotoxicity induced by fluoroquinolones. Eur J Pharmacol 835:94\u2013107. https:\/\/doi.org\/10.1016\/j.ejphar.2018.08.002","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"5960_CR17","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.3892\/ijo.2018.4310","volume":"52","author":"A Beberok","year":"2018","unstructured":"Beberok A, Wrze\u015bniok D, Rzepka Z, Respondek M, Buszman E (2018) Ciprofloxacin triggers the apoptosis of human triple-negative breast cancer MDA-MB-231 cells via the p53\/Bax\/Bcl-2 signaling pathway. Int J Oncol 52(5):1727\u20131737. https:\/\/doi.org\/10.3892\/ijo.2018.4310","journal-title":"Int J Oncol"},{"issue":"1","key":"5960_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/bmb\/ldz006","volume":"130","author":"DR Bisaccia","year":"2019","unstructured":"Bisaccia DR, Aicale R, Tarantino D, Peretti GM, Maffulli N (2019) Biological and chemical changes in fluoroquinolone-associated tendinopathies: a systematic review. Br Med Bull 130(1):39\u201349. https:\/\/doi.org\/10.1093\/bmb\/ldz006","journal-title":"Br Med Bull"},{"issue":"3","key":"5960_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.1476-5381.2009.00161.x","volume":"157","author":"LA Bourikas","year":"2009","unstructured":"Bourikas LA, Kolios G, Valatas V, Notas G, Drygiannakis I, Pelagiadis I et al (2009) Ciprofloxacin decreases survival in HT-29 cells via the induction of TGF-\u03b21 secretion and enhances the anti-proliferative effect of 5-fluorouracil. Br J Pharmacol 157(3):362\u2013370. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00161.x","journal-title":"Br J Pharmacol"},{"issue":"4","key":"5960_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3322\/caac.21492","volume":"70","author":"F Bray","year":"2020","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A (2020) Erratum: global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J Clin 70(4):313. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"Ca Cancer J Clin"},{"issue":"1","key":"5960_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","volume":"34","author":"A Cervantes","year":"2023","unstructured":"Cervantes A, Adam R, Rosell\u00f3 S, Arnold D, Normanno N, Ta\u00efeb J et al (2023) Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up\u2606. Ann Oncol 34(1):10\u201332. https:\/\/doi.org\/10.1016\/j.annonc.2022.10.003","journal-title":"Ann Oncol"},{"issue":"9","key":"5960_CR22","doi-asserted-by":"publisher","first-page":"6304","DOI":"10.1039\/d2ra07005g","volume":"13","author":"M Chang","year":"2023","unstructured":"Chang M (2023) Matrix metalloproteinase profiling and their roles in disease. RSC Adv 13(9):6304\u20136316. https:\/\/doi.org\/10.1039\/d2ra07005g","journal-title":"RSC Adv"},{"issue":"11","key":"5960_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e32571","volume":"10","author":"F Chen","year":"2024","unstructured":"Chen F, Tang H, Lin J, Kang R, Tang D, Liu J (2024) Ciprofloxacin is a novel anti-ferroptotic antibiotic. Heliyon 10(11):e32571. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32571","journal-title":"Heliyon"},{"issue":"13","key":"5960_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cells14131010","volume":"14","author":"J-S Chen","year":"2025","unstructured":"Chen J-S, Chi C-W, Lai C-T, Wu S-H, Shieh H-R, Yen J-C et al (2025) Ciprofloxacin exerts anti-tumor effects in vivo through cGAS-STING activation and modulates tumor microenvironment. Cells 14(13):1010. https:\/\/doi.org\/10.3390\/cells14131010","journal-title":"Cells"},{"key":"5960_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111810","volume":"185","author":"A Chrzanowska","year":"2020","unstructured":"Chrzanowska A, Roszkowski P, Bielenica A, Olejarz W, St\u0119pie\u0144 K, Struga M (2020) Anticancer and antimicrobial effects of novel ciprofloxacin fatty acids conjugates. Eur J Med Chem 185:111810. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111810","journal-title":"Eur J Med Chem"},{"issue":"2","key":"5960_CR26","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3390\/cancers14020409","volume":"14","author":"A Chrzanowska","year":"2022","unstructured":"Chrzanowska A, Olejarz W, Kubiak-Tomaszewska G, Ciechanowicz AK, Struga M (2022) The effect of fatty acids on ciprofloxacin cytotoxic activity in prostate cancer cell lines\u2014does lipid component enhance anticancer ciprofloxacin potential? Cancers 14(2):409. https:\/\/doi.org\/10.3390\/cancers14020409","journal-title":"Cancers"},{"issue":"11","key":"5960_CR27","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1002\/art.10617","volume":"46","author":"AN Corps","year":"2002","unstructured":"Corps AN, Harrall RL, Curry VA, Fenwick SA, Hazleman BL, Riley GP (2002) Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1\u03b2 in human tendon-derived cells: a potential mechanism of fluoroquinolone-induced tendinopathy. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology 46(11):3034\u20133040. https:\/\/doi.org\/10.1002\/art.10617","journal-title":"Arthritis & Rheumatism: Official Journal of the American College of Rheumatology"},{"issue":"11","key":"5960_CR28","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1093\/rheumatology\/keg372","volume":"42","author":"A Corps","year":"2003","unstructured":"Corps A, Curry V, Harrall R, Dutt D, Hazleman B, Riley G (2003) Ciprofloxacin reduces the stimulation of prostaglandin E2 output by interleukin-1 \u03b2 in human tendon-derived cells. Rheumatology 42(11):1306\u20131310. https:\/\/doi.org\/10.1093\/rheumatology\/keg372","journal-title":"Rheumatology"},{"key":"5960_CR29","unstructured":"DailyMed. Ciprofloxacin tablet, film coated: DailyMed; 2026 [updated August 11, 2026. Available from: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=922e9f5c-cc59-4d9e-bf42-a4b900d077ed&utm_source."},{"issue":"4","key":"5960_CR30","first-page":"273","volume":"7","author":"Q Dang","year":"2019","unstructured":"Dang Q, Chen Y-A, Hsieh J-T (2019) The dysfunctional lipids in prostate cancer. American Journal of Clinical and Experimental Urology 7(4):273\u2013280","journal-title":"American Journal of Clinical and Experimental Urology"},{"issue":"1","key":"5960_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008558","volume":"16","author":"JR Delaney","year":"2020","unstructured":"Delaney JR, Patel CB, Bapat J, Jones CM, Ramos-Zapatero M, Ortell KK et al (2020) Autophagy gene haploinsufficiency drives chromosome instability, increases migration, and promotes early ovarian tumors. PLoS Genet 16(1):e1008558. https:\/\/doi.org\/10.1371\/journal.pgen.1008558","journal-title":"PLoS Genet"},{"issue":"1","key":"5960_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/jac\/33.1.111","volume":"33","author":"R Echols","year":"1994","unstructured":"Echols R, Weinstein MP, O\u2019Keeffe B, Shah A, Heller AH (1994) Comparative crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin and ofloxacin. J Antimicrob Chemother 33(1):111\u2013118. https:\/\/doi.org\/10.1093\/jac\/33.1.111","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"5960_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3892\/or.2020.7602","volume":"44","author":"M Fan","year":"2020","unstructured":"Fan M, Chen S, Weng Y, Li X, Jiang Y, Wang X et al (2020) Ciprofloxacin promotes polarization of CD86+ CD206\u2212 macrophages to suppress liver cancer. Oncol Rep 44(1):91\u2013102. https:\/\/doi.org\/10.3892\/or.2020.7602","journal-title":"Oncol Rep"},{"issue":"3","key":"5960_CR34","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1086\/600122","volume":"200","author":"B Fantin","year":"2009","unstructured":"Fantin B, Duval X, Massias L, Alavoine L, Chau F, Retout S et al (2009) Ciprofloxacin dosage and emergence of resistance in human commensal bacteria. J Infect Dis 200(3):390\u2013398. https:\/\/doi.org\/10.1086\/600122","journal-title":"J Infect Dis"},{"key":"5960_CR35","doi-asserted-by":"publisher","unstructured":"Fathy M, Sun S, Zhao Q-L, Abdel-Aziz M, Abuo-Rahma GE-DA, Awale S, et al. A new ciprofloxacin-derivative inhibits proliferation and suppresses the migration ability of HeLa cells. Anticancer Research. 2020;40(9):5025\u201333. https:\/\/doi.org\/10.21873\/anticanres.14505","DOI":"10.21873\/anticanres.14505"},{"key":"5960_CR36","doi-asserted-by":"publisher","unstructured":"Fawzy MA, Abu-Baih RH, Abuo-Rahma GE-DA, Abdel-Rahman IM, El-Sheikh AA, Nazmy MH. In vitro anticancer activity of novel ciprofloxacin Mannich base in lung adenocarcinoma and high-grade serous ovarian cancer cell lines via attenuating MAPK signaling pathway. Molecules. 2023;28(3):1137. https:\/\/doi.org\/10.3390\/molecules28031137","DOI":"10.3390\/molecules28031137"},{"issue":"12","key":"5960_CR37","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.3390\/cancers16122227","volume":"16","author":"N Ferrario","year":"2024","unstructured":"Ferrario N, Marras E, Vivona V, Randisi F, Fallica AN, Marrazzo A et al (2024) Mechanisms of the antineoplastic effects of new fluoroquinolones in 2D and 3D human breast and bladder cancer cell lines. Cancers (Basel) 16(12):2227. https:\/\/doi.org\/10.3390\/cancers16122227","journal-title":"Cancers (Basel)"},{"key":"5960_CR38","volume-title":"Cervical cancer (nursing)","author":"JR Fowler","year":"2023","unstructured":"Fowler JR, Maani EV, Dunton CJ, Gasalberti DP, Jack BW, Miller JL (2023) Cervical cancer (nursing). StatPearls Publishing, Treasure Island (FL)"},{"issue":"3","key":"5960_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058389","volume":"8","author":"R Fukumoto","year":"2013","unstructured":"Fukumoto R, Cary LH, Gorbunov NV, Lombardini ED, Elliott TB, Kiang JG (2013) Ciprofloxacin modulates cytokine\/chemokine profile in serum, improves bone marrow repopulation, and limits apoptosis and autophagy in ileum after whole body ionizing irradiation combined with skin-wound trauma. PLoS ONE 8(3):e58389. https:\/\/doi.org\/10.1371\/journal.pone.0058389","journal-title":"PLoS ONE"},{"issue":"17","key":"5960_CR40","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.7150\/jca.47470","volume":"11","author":"Y Gao","year":"2020","unstructured":"Gao Y, Shang Q, Li W, Guo W, Stojadinovic A, Mannion C et al (2020) Antibiotics for cancer treatment: a double-edged sword. J Cancer 11(17):5135\u20135149. https:\/\/doi.org\/10.7150\/jca.47470","journal-title":"J Cancer"},{"issue":"11","key":"5960_CR41","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1128\/AAC.35.11.2215","volume":"35","author":"R Garraffo","year":"1991","unstructured":"Garraffo R, Jambou D, Chichmanian RM, Ravoire S, Lapalus P (1991) In vitro and in vivo ciprofloxacin pharmacokinetics in human neutrophils. Antimicrob Agents Chemother 35(11):2215\u20132218. https:\/\/doi.org\/10.1128\/AAC.35.11.2215","journal-title":"Antimicrob Agents Chemother"},{"issue":"1\u20132","key":"5960_CR42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000475529","volume":"85","author":"S Gatius","year":"2018","unstructured":"Gatius S, Cuevas D, Fern\u00e1ndez C, Roman-Canal B, Adamoli V, Piulats JM et al (2018) Tumor heterogeneity in endometrial carcinoma: practical consequences. Pathobiology 85(1\u20132):35\u201340. https:\/\/doi.org\/10.1159\/000475529","journal-title":"Pathobiology"},{"key":"5960_CR43","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ajem.2022.03.008","volume":"55","author":"TV Giannouchos","year":"2022","unstructured":"Giannouchos TV, Gomez-Lumbreras A, Malone DC (2022) Risk of tizanidine-induced adverse events after concomitant exposure to ciprofloxacin: a cohort study in the U.S. Am J Emerg Med 55:147\u2013151. https:\/\/doi.org\/10.1016\/j.ajem.2022.03.008","journal-title":"Am J Emerg Med"},{"key":"5960_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2025.130432","volume":"130","author":"NV Gone","year":"2026","unstructured":"Gone NV, Sharma T, Joshi R, Upreti A, Santra M, Sanjayan GJ (2026) Repurposed ciprofloxacin derivatives as potent autophagic-type anticancer agents. Bioorg Med Chem Lett 130:130432. https:\/\/doi.org\/10.1016\/j.bmcl.2025.130432","journal-title":"Bioorg Med Chem Lett"},{"issue":"9","key":"5960_CR45","doi-asserted-by":"publisher","first-page":"14299","DOI":"10.1007\/s00210-026-05338-1","volume":"399","author":"MO Gonen","year":"2026","unstructured":"Gonen MO, Akaras N, Simsek H, Kandemir O, Caglayan C, Aygormez S et al (2026) Chrysin mitigates ciprofloxacin-induced nephrotoxicity: associations with notch\/HES1 signaling, inflammation, and a ferroptosis-related molecular signature. Naunyn Schmiedebergs Arch Pharmacol 399(9):14299\u201314313. https:\/\/doi.org\/10.1007\/s00210-026-05338-1","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"5960_CR46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M et al (2024) NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther 9(1):53. https:\/\/doi.org\/10.1038\/s41392-024-01757-9","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"5960_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020268","volume":"20","author":"P Gupta","year":"2019","unstructured":"Gupta P, Gao H-L, Ashar YV, Karadkhelkar NM, Yoganathan S, Chen Z-S (2019) Ciprofloxacin enhances the chemosensitivity of cancer cells to ABCB1 substrates. Int J Mol Sci 20(2):268. https:\/\/doi.org\/10.3390\/ijms20020268","journal-title":"Int J Mol Sci"},{"issue":"5","key":"5960_CR48","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/153765291009877","volume":"15","author":"A G\u00fcrbay","year":"2005","unstructured":"G\u00fcrbay A, Osman M, Favier A, Hincal F (2005) Ciprofloxacin-induced cytotoxicity and apoptosis in HeLa cells. Toxicol Mech Methods 15(5):339\u2013342. https:\/\/doi.org\/10.1080\/153765291009877","journal-title":"Toxicol Mech Methods"},{"key":"5960_CR49","unstructured":"Gurtowska N, Kloskowski T, Drewa T. Ciprofloxacin criteria in antimicrobial prophylaxis and bladder cancer recurrence. Medical science monitor: international medical journal of experimental and clinical research. 2010;16(10):RA218\u201323."},{"issue":"18","key":"5960_CR50","doi-asserted-by":"publisher","first-page":"9625","DOI":"10.1093\/nar\/gky793","volume":"46","author":"A Hangas","year":"2018","unstructured":"Hangas A, Aasumets K, Kekalainen NJ, Paloheina M, Pohjoismaki JL, Gerhold JM et al (2018) Ciprofloxacin impairs mitochondrial DNA replication initiation through inhibition of Topoisomerase 2. Nucleic Acids Res 46(18):9625\u20139636. https:\/\/doi.org\/10.1093\/nar\/gky793","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"5960_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ph18010072","volume":"18","author":"HM Hassan","year":"2025","unstructured":"Hassan HM, Hassan R, Elmagzoub RM, Al-Emam A, Kossenas K, Abdel-Samea AS et al (2025) From infection to tumor: exploring the therapeutic potential of ciprofloxacin derivatives as anticancer agents. Pharmaceuticals (Basel) 18(1):72. https:\/\/doi.org\/10.3390\/ph18010072","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"5960_CR52","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/sj.bjc.6600079","volume":"86","author":"C Herold","year":"2002","unstructured":"Herold C, Ocker M, Ganslmayer M, Gerauer H, Hahn E, Schuppan D (2002) Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells. Br J Cancer 86(3):443\u2013448. https:\/\/doi.org\/10.1038\/sj.bjc.6600079","journal-title":"Br J Cancer"},{"issue":"23","key":"5960_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21238974","volume":"21","author":"T Ichimiya","year":"2020","unstructured":"Ichimiya T, Yamakawa T, Hirano T, Yokoyama Y, Hayashi Y, Hirayama D et al (2020) Autophagy and autophagy-related diseases: a review. Int J Mol Sci 21(23):8974. https:\/\/doi.org\/10.3390\/ijms21238974","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5960_CR54","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00210-025-04508-x","volume":"399","author":"M Ishaq","year":"2026","unstructured":"Ishaq M, Zafar E, Maqbool MF, Mansha M, Khan M, Li Y (2026) Repurposing fluoroquinolones as cancer chemosensitizers: a way to overcome cancer therapeutic bottleneck. Naunyn Schmiedebergs Arch Pharmacol 399(1):47\u201362. https:\/\/doi.org\/10.1007\/s00210-025-04508-x","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5960_CR55","doi-asserted-by":"publisher","unstructured":"Jaber DF, Jallad M-AN, Abdelnoor AM. The effect of ciprofloxacin on the growth of B16F10 melanoma cells. Journal of cancer research and therapeutics. 2017;13(6):956\u201360. https:\/\/doi.org\/10.4103\/0973-1482.180610","DOI":"10.4103\/0973-1482.180610"},{"issue":"1","key":"5960_CR56","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/10799893.2014.975246","volume":"36","author":"I Jemel-Oualha","year":"2016","unstructured":"Jemel-Oualha I, Elloumi-Mseddi J, Beji A, Hakim B, Aifa S (2016) Controversial effect on Erk activation of some cytotoxic drugs in human LOVO colon cancer cells. J Recept Signal Transduction 36(1):21\u201325. https:\/\/doi.org\/10.3109\/10799893.2014.975246","journal-title":"J Recept Signal Transduction"},{"issue":"1","key":"5960_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-024-01809-5","volume":"17","author":"C Jing","year":"2025","unstructured":"Jing C, Wu Y, Zhang Y, Zhu Z, Zhang Y, Liu Z et al (2025) Epigenetic regulation and post-translational modifications of ferroptosis-related factors in cardiovascular diseases. Clin Epigenetics 17(1):4. https:\/\/doi.org\/10.1186\/s13148-024-01809-5","journal-title":"Clin Epigenetics"},{"issue":"4","key":"5960_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.idnow.2025.105064","volume":"55","author":"AP Jonville-Bera","year":"2025","unstructured":"Jonville-Bera AP, Largeau B, di Meglio F, Pariente A (2025) The safety profile of fluoroquinolones. Infect Dis Now 55(4):105064. https:\/\/doi.org\/10.1016\/j.idnow.2025.105064","journal-title":"Infect Dis Now"},{"key":"5960_CR59","doi-asserted-by":"publisher","unstructured":"Jumaa AH, Hade IM, Abdulla KN, Yasin YS. Ciprofloxacin and metformin as dual therapeutic agents: synergistic impact on cervical cancer cell line proliferation: insight into cytoplasmic SRC tyrosine kinase targeting. Asian Pacific Journal of Cancer Biology. 2025;10(3):699\u2013712. https:\/\/doi.org\/10.31557\/apjcb.2025.10.3.699-712","DOI":"10.31557\/apjcb.2025.10.3.699-712"},{"issue":"12","key":"5960_CR60","doi-asserted-by":"publisher","first-page":"5530","DOI":"10.3390\/ijms26125530","volume":"26","author":"Y Kabalan","year":"2025","unstructured":"Kabalan Y, Matulewicz K, Tylkowski B, Wozniak-Budych M, Staszak K, Montane X et al (2025) Investigation of anti-cancer properties of nano-encapsulated ciprofloxacin using 3D cancer cell spheroids as tumour models. Int J Mol Sci 26(12):5530. https:\/\/doi.org\/10.3390\/ijms26125530","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5960_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-025-02619-2","volume":"42","author":"SH Kadhim","year":"2025","unstructured":"Kadhim SH, Dehghan G, Mahdavi M (2025) Ciprofloxacin-encapsulated solid lipid nanoparticles: a comprehensive biochemical analysis of cytotoxic effects, proliferation inhibition, and apoptotic induction in KG1-a leukemia cells. Med Oncol 42(3):75. https:\/\/doi.org\/10.1007\/s12032-025-02619-2","journal-title":"Med Oncol"},{"issue":"9","key":"5960_CR62","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.4049\/jimmunol.0901662","volume":"184","author":"MM Kami\u0144ski","year":"2010","unstructured":"Kami\u0144ski MM, Sauer SW, Klemke C-D, S\u00fcss D, Okun JG, Krammer PH et al (2010) Mitochondrial reactive oxygen species control T cell activation by regulating IL-2 and IL-4 expression: mechanism of ciprofloxacin-mediated immunosuppression. J Immunol 184(9):4827\u20134841. https:\/\/doi.org\/10.4049\/jimmunol.0901662","journal-title":"J Immunol"},{"issue":"12","key":"5960_CR63","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3390\/brainsci8120203","volume":"8","author":"RE Kast","year":"2018","unstructured":"Kast RE, Skuli N, Sardi I, Capanni F, Hessling M, Frosina G et al (2018) Augmentation of 5-aminolevulinic acid treatment of glioblastoma by adding ciprofloxacin, deferiprone, 5-fluorouracil and febuxostat: the CAALA regimen. Brain Sci 8(12):203. https:\/\/doi.org\/10.3390\/brainsci8120203","journal-title":"Brain Sci"},{"key":"5960_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118457","volume":"191","author":"A Kazemi","year":"2025","unstructured":"Kazemi A, Fathy M, Jahanian A, Khanali J, Ostadi Y, Babajani A et al (2025) The role of MMPs and TIMPs in regenerative medicine: from pathological ECM remodeling to therapeutic applications. Biomed Pharmacother 191:118457. https:\/\/doi.org\/10.1016\/j.biopha.2025.118457","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"5960_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-023-00383-3","volume":"20","author":"H-J Kim","year":"2023","unstructured":"Kim H-J, Kim H, Lee J-H, Hwangbo C (2023) Toll-like receptor 4 (TLR4): new insight immune and aging. Immunity Ageing 20(1):67. https:\/\/doi.org\/10.1186\/s12979-023-00383-3","journal-title":"Immunity Ageing"},{"issue":"6","key":"5960_CR66","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.3892\/ijo.2012.1653","volume":"41","author":"T Kloskowski","year":"2012","unstructured":"Kloskowski T, Gurtowska N, Olkowska J, Nowak JM, Adamowicz J, Tworkiewicz J et al (2012) Ciprofloxacin is a potential topoisomerase II inhibitor for the treatment of NSCLC. Int J Oncol 41(6):1943\u20131949. https:\/\/doi.org\/10.3892\/ijo.2012.1653","journal-title":"Int J Oncol"},{"issue":"21","key":"5960_CR67","doi-asserted-by":"publisher","first-page":"11970","DOI":"10.3390\/ijms222111970","volume":"22","author":"T Kloskowski","year":"2021","unstructured":"Kloskowski T, Szeliski K, Fekner Z, Rasmus M, D\u0105browski P, Wolska A et al (2021) Ciprofloxacin and levofloxacin as potential drugs in genitourinary cancer treatment\u2014the effect of dose\u2013response on 2D and 3D cell cultures. Int J Mol Sci 22(21):11970. https:\/\/doi.org\/10.3390\/ijms222111970","journal-title":"Int J Mol Sci"},{"key":"5960_CR68","doi-asserted-by":"crossref","unstructured":"Kloskowski T, Gurtowska N, Nowak M, Joachimiak R, Bajek A, Olkowska J, et al. The influence of ciprofloxacin on viability of A549, HepG2, A375. S2, B16 and C6 cell lines in vitro. Acta Pol Pharm. 2011;68(6):859\u201365.","DOI":"10.5506\/APhysPolB.42.859"},{"key":"5960_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108863","volume":"164","author":"D Koszelewski","year":"2025","unstructured":"Koszelewski D, Ostaszewski R, Zaremba A, Riganti C, Kopecka J, Contino M et al (2025) New dimension of ciprofloxacin hybrids: synthesis, characterization and anticancer evaluation of newly C3-modified ciprofloxacin derivatives. Bioorg Chem 164:108863. https:\/\/doi.org\/10.1016\/j.bioorg.2025.108863","journal-title":"Bioorg Chem"},{"issue":"11","key":"5960_CR70","first-page":"1835","volume":"46","author":"O Langer","year":"2005","unstructured":"Langer O, Karch R, Muller U, Dobrozemsky G, Abrahim A, Zeitlinger M et al (2005) Combined PET and microdialysis for in vivo assessment of intracellular drug pharmacokinetics in humans. J Nucl Med 46(11):1835\u20131841","journal-title":"J Nucl Med"},{"issue":"4","key":"5960_CR71","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/jac\/dkf179","volume":"50","author":"M Leone","year":"2002","unstructured":"Leone M, Sampol-Manos E, Santelli D, Grabowski S, Alliez B, Durand A et al (2002) Brain tissue penetration of ciprofloxacin following a single intravenous dose. J Antimicrob Chemother 50(4):607\u2013609. https:\/\/doi.org\/10.1093\/jac\/dkf179","journal-title":"J Antimicrob Chemother"},{"key":"5960_CR72","volume-title":"Bladder cancer","author":"SW Leslie","year":"2025","unstructured":"Leslie SW, Soon-Sutton TL, Aeddula NR (2025) Bladder cancer. StatPearls Publishing, Treasure Island (FL)"},{"issue":"10","key":"5960_CR73","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.3390\/ijms19103187","volume":"19","author":"EJ Lim","year":"2018","unstructured":"Lim EJ, Yoon YJ, Heo J, Lee TH, Kim Y-H (2018) Ciprofloxacin enhances TRAIL-induced apoptosis in lung cancer cells by upregulating the expression and protein stability of death receptors through CHOP expression. Int J Mol Sci 19(10):3187. https:\/\/doi.org\/10.3390\/ijms19103187","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5960_CR74","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s40262-026-01620-w","volume":"65","author":"M Mehciz","year":"2026","unstructured":"Mehciz M, Rietveld PCS, Koch BCP, Preijers T (2026) Methodologies for population pharmacokinetic modeling of target-site drug exposure: a narrative review of current strategies. Clin Pharmacokinet 65(4):497\u2013513. https:\/\/doi.org\/10.1007\/s40262-026-01620-w","journal-title":"Clin Pharmacokinet"},{"key":"5960_CR75","volume-title":"Gastric cancer","author":"G Menon","year":"2025","unstructured":"Menon G, El-Nakeep S, Babiker HM (2025) Gastric cancer. StatPearls Publishing, Treasure Island (FL)"},{"issue":"19","key":"5960_CR76","doi-asserted-by":"publisher","first-page":"4636","DOI":"10.1016\/j.bmc.2016.07.070","volume":"24","author":"HH Mohammed","year":"2016","unstructured":"Mohammed HH, Abd El-Hafeez AA, Abbas SH, Abdelhafez E-SM, Abuo-Rahma GE-DA (2016) New antiproliferative 7-(4-(N-substituted carbamoylmethyl) piperazin-1-yl) derivatives of ciprofloxacin induce cell cycle arrest at G2\/M phase. Bioorg Med Chem 24(19):4636\u20134646. https:\/\/doi.org\/10.1016\/j.bmc.2016.07.070","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"5960_CR77","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1080\/14756366.2022.2072308","volume":"37","author":"HH Mohammed","year":"2022","unstructured":"Mohammed HH, Abd El-Hafeez AA, Ebeid K, Mekkawy AI, Abourehab MA, Wafa EI et al (2022) New 1, 2, 3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I & II and tubulin polymerization. J Enzyme Inhib Med Chem 37(1):1346\u20131363. https:\/\/doi.org\/10.1080\/14756366.2022.2072308","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"2","key":"5960_CR78","first-page":"196","volume":"5","author":"E Mondal","year":"2004","unstructured":"Mondal E, Das S, Mukherjee P (2004) Comparative evaluation of antiproliferative activity and induction of apoptosis by some fluoroquinolones on a human non-small cell lung cancer cell line in culture. Asian Pac J Cancer Prev 5(2):196\u2013204","journal-title":"Asian Pac J Cancer Prev"},{"issue":"13","key":"5960_CR79","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1038\/s41388-022-02221-0","volume":"41","author":"A Mota","year":"2022","unstructured":"Mota A, Oltra SS, Selenica P, Moiola CP, Casas-Arozamena C, L\u00f3pez-Gil C et al (2022) Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression. Oncogene 41(13):1835\u20131850. https:\/\/doi.org\/10.1038\/s41388-022-02221-0","journal-title":"Oncogene"},{"issue":"41","key":"5960_CR80","doi-asserted-by":"publisher","first-page":"2302931","DOI":"10.1002\/smll.202302931","volume":"20","author":"YW Naguib","year":"2024","unstructured":"Naguib YW, Alhaj-Suliman SO, Wafa EI, Saha S, Ebeid K, Mohammed HH et al (2024) Ciprofloxacin derivative-loaded nanoparticles synergize with paclitaxel against type II human endometrial cancer. Small 20(41):2302931. https:\/\/doi.org\/10.1002\/smll.202302931","journal-title":"Small"},{"issue":"4","key":"5960_CR81","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/bab.2578","volume":"71","author":"D Najafi","year":"2024","unstructured":"Najafi D, Siri G, Sadri M, Yazdani O, Esbati R, Karimi P et al (2024) Combination MEG3 lncRNA and ciprofloxacin dramatically decreases cell migration and viability as well as induces apoptosis in GC cells in vitro. Biotechnol Appl Biochem 71(4):809\u2013816. https:\/\/doi.org\/10.1002\/bab.2578","journal-title":"Biotechnol Appl Biochem"},{"issue":"5","key":"5960_CR82","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/path.5025","volume":"244","author":"K Nesic","year":"2018","unstructured":"Nesic K, Wakefield M, Kondrashova O, Scott CL, McNeish IA (2018) Targeting DNA repair: the genome as a potential biomarker. J Pathol 244(5):586\u2013597. https:\/\/doi.org\/10.1002\/path.5025","journal-title":"J Pathol"},{"issue":"5","key":"5960_CR83","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s40262-021-01091-1","volume":"61","author":"Z Oesterreicher","year":"2022","unstructured":"Oesterreicher Z, Eberl S, Wulkersdorfer B, Matzneller P, Eder C, van Duijn E et al (2022) Microdosing as a potential tool to enhance clinical development of novel antibiotics: a tissue and plasma PK feasibility study with ciprofloxacin. Clin Pharmacokinet 61(5):697\u2013707. https:\/\/doi.org\/10.1007\/s40262-021-01091-1","journal-title":"Clin Pharmacokinet"},{"issue":"40","key":"5960_CR84","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000039888","volume":"103","author":"WY Park","year":"2024","unstructured":"Park WY, Lim S-H, Kim Y, Paek JH, Jin K, Han S et al (2024) Impact of ciprofloxacin with autophagy on renal tubular injury. Medicine (Baltimore) 103(40):e39888. https:\/\/doi.org\/10.1097\/MD.0000000000039888","journal-title":"Medicine (Baltimore)"},{"key":"5960_CR85","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jphotobiol.2014.07.006","volume":"140","author":"P Perucca","year":"2014","unstructured":"Perucca P, Savio M, Cazzalini O, Mocchi R, Maccario C, Sommatis S et al (2014) Structure\u2013activity relationship and role of oxygen in the potential antitumour activity of fluoroquinolones in human epithelial cancer cells. J Photochem Photobiol, B 140:57\u201368. https:\/\/doi.org\/10.1016\/j.jphotobiol.2014.07.006","journal-title":"J Photochem Photobiol, B"},{"key":"5960_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbi.2016.03.005","volume":"250","author":"PP Phiboonchaiyanan","year":"2016","unstructured":"Phiboonchaiyanan PP, Kiratipaiboon C, Chanvorachote P (2016) Ciprofloxacin mediates cancer stem cell phenotypes in lung cancer cells through caveolin-1-dependent mechanism. Chem Biol Interact 250:1\u201311. https:\/\/doi.org\/10.1016\/j.cbi.2016.03.005","journal-title":"Chem Biol Interact"},{"issue":"3","key":"5960_CR87","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00280-008-0892-6","volume":"64","author":"AC Pinto","year":"2009","unstructured":"Pinto AC, Moreira JN, Sim\u00f5es S (2009) Ciprofloxacin sensitizes hormone-refractory prostate cancer cell lines to doxorubicin and docetaxel treatment on a schedule-dependent manner. Cancer Chemother Pharmacol 64(3):445\u2013454. https:\/\/doi.org\/10.1007\/s00280-008-0892-6","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"5960_CR88","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00280-010-1315-z","volume":"67","author":"AC Pinto","year":"2011","unstructured":"Pinto AC, \u00c2ngelo S, Moreira JN, Sim\u00f5es S (2011) Schedule treatment design and quantitative in vitro evaluation of chemotherapeutic combinations for metastatic prostate cancer therapy. Cancer Chemother Pharmacol 67(2):275\u2013284. https:\/\/doi.org\/10.1007\/s00280-010-1315-z","journal-title":"Cancer Chemother Pharmacol"},{"key":"5960_CR89","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.humpath.2018.06.018","volume":"80","author":"J Prat","year":"2018","unstructured":"Prat J, D\u2019Angelo E, Espinosa I (2018) Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics. Hum Pathol 80:11\u201327. https:\/\/doi.org\/10.1016\/j.humpath.2018.06.018","journal-title":"Hum Pathol"},{"key":"5960_CR90","volume-title":"Pancreatic cancer","author":"Y Puckett","year":"2025","unstructured":"Puckett Y, Garfield K (2025) Pancreatic cancer. StatPearls Publishing, Treasure Island (FL)"},{"issue":"12","key":"5960_CR91","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1111\/cas.70199","volume":"116","author":"Y Qiao","year":"2025","unstructured":"Qiao Y, Kida Y, Lai X, Koshikawa N, Igarashi R, Takatori A et al (2025) Anticancer effect of the triphenylphosphonium-conjugated quinolone antibiotics targeting mitochondrial DNA replication. Cancer Sci 116(12):3431\u20133441. https:\/\/doi.org\/10.1111\/cas.70199","journal-title":"Cancer Sci"},{"issue":"1","key":"5960_CR92","doi-asserted-by":"publisher","first-page":"153","DOI":"10.7150\/jca.34693","volume":"11","author":"S Qin","year":"2020","unstructured":"Qin S, Yi M, Jiao D, Li A, Wu K (2020) Distinct roles of VEGFA and ANGPT2 in lung adenocarcinoma and squamous cell carcinoma. J Cancer 11(1):153. https:\/\/doi.org\/10.7150\/jca.34693","journal-title":"J Cancer"},{"issue":"9","key":"5960_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2020.158753","volume":"1865","author":"M Roman","year":"2020","unstructured":"Roman M, Wrobel TP, Panek A, Paluszkiewicz C, Kwiatek WM (2020) Lipid droplets in prostate cancer cells and effect of irradiation studied by Raman microspectroscopy. Biochimica Et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids 1865(9):158753. https:\/\/doi.org\/10.1016\/j.bbalip.2020.158753","journal-title":"Biochimica Et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids"},{"issue":"11","key":"5960_CR94","doi-asserted-by":"publisher","first-page":"5379","DOI":"10.3390\/ijms26115379","volume":"26","author":"J Sailer","year":"2025","unstructured":"Sailer J, Schmitt S, Zischka H, Gnaiger E (2025) Direct effects of clinically relevant antibiotics on mitochondrial respiration. Int J Mol Sci 26(11):5379. https:\/\/doi.org\/10.3390\/ijms26115379","journal-title":"Int J Mol Sci"},{"key":"5960_CR95","doi-asserted-by":"publisher","unstructured":"Salih SR, Abdulla KN, Awn AK, Yasin YS, Jumaa AH. Impact of esomeprazole, ciprofloxacin and their combination on cervical cancer cell line proliferation: a focus on heat shock protein 70 modulation. Asian Pacific Journal of Cancer Prevention: APJCP. 2025;26(7):2455. https:\/\/doi.org\/10.31557\/APJCP.2025.26.7.2455","DOI":"10.31557\/APJCP.2025.26.7.2455"},{"issue":"1","key":"5960_CR96","first-page":"42","volume":"25","author":"P Saraon","year":"2014","unstructured":"Saraon P, Drabovich AP, Jarvi KA, Diamandis EP (2014) Mechanisms of androgen-independent prostate cancer. Ejifcc 25(1):42\u201354","journal-title":"Ejifcc"},{"issue":"4","key":"5960_CR97","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3109\/14756360903373350","volume":"25","author":"PC Sharma","year":"2010","unstructured":"Sharma PC, Jain A, Jain S, Pahwa R, Yar MS (2010) Ciprofloxacin: review on developments in synthetic, analytical, and medicinal aspects. J Enzyme Inhib Med Chem 25(4):577\u2013589. https:\/\/doi.org\/10.3109\/14756360903373350","journal-title":"J Enzyme Inhib Med Chem"},{"key":"5960_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtchem.2020.100296","volume":"17","author":"P Sharma","year":"2020","unstructured":"Sharma P, Goyal R, Sharma A, Sharma D, Saini N, Rajak H et al (2020) Insights on fluoroquinolones in cancer therapy: chemistry and recent developments. Materials Today Chemistry 17:100296. https:\/\/doi.org\/10.1016\/j.mtchem.2020.100296","journal-title":"Materials Today Chemistry"},{"issue":"2","key":"5960_CR99","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/aps.2011.158","volume":"33","author":"Z-y Shi","year":"2012","unstructured":"Shi Z-y, Li Y-q, Kang Y-h, Hu G-q, Huang-Fu C-s, Deng J-b et al (2012) Piperonal ciprofloxacin hydrazone induces growth arrest and apoptosis of human hepatocarcinoma SMMC-7721 cells. Acta Pharmacol Sin 33(2):271\u2013278. https:\/\/doi.org\/10.1038\/aps.2011.158","journal-title":"Acta Pharmacol Sin"},{"key":"5960_CR100","doi-asserted-by":"publisher","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA: a cancer journal for clinicians. 2018;68(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21442","DOI":"10.3322\/caac.21442"},{"issue":"11","key":"5960_CR101","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1093\/jac\/dkac254","volume":"77","author":"L Silva Lagos","year":"2022","unstructured":"Silva Lagos L, Luu TV, De Haan B, Faas M, De Vos P (2022) TLR2 and TLR4 activity in monocytes and macrophages after exposure to amoxicillin, ciprofloxacin, doxycycline and erythromycin. J Antimicrob Chemother 77(11):2972\u20132983. https:\/\/doi.org\/10.1093\/jac\/dkac254","journal-title":"J Antimicrob Chemother"},{"key":"5960_CR102","doi-asserted-by":"publisher","unstructured":"Stewardson AJ, Gaia N, Francois P, Malhotra-Kumar S, Delemont C, Martinez de Tejada B, et al. Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: a culture-free analysis of gut microbiota. Clin Microbiol Infect. 2015;21(4):344 e1\u201311. https:\/\/doi.org\/10.1016\/j.cmi.2014.11.016","DOI":"10.1016\/j.cmi.2014.11.016"},{"issue":"14","key":"5960_CR103","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR (2022) Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell 185(14):2401\u20132421. https:\/\/doi.org\/10.1016\/j.cell.2022.06.003","journal-title":"Cell"},{"issue":"11","key":"5960_CR104","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.3390\/ijms20112626","volume":"20","author":"GE Stoykova","year":"2019","unstructured":"Stoykova GE, Schlaepfer IR (2019) Lipid metabolism and endocrine resistance in prostate cancer, and new opportunities for therapy. Int J Mol Sci 20(11):2626. https:\/\/doi.org\/10.3390\/ijms20112626","journal-title":"Int J Mol Sci"},{"issue":"10","key":"5960_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.110653","volume":"301","author":"H Tang","year":"2025","unstructured":"Tang H, Chen F, Cai X, Lin J, Xiang L, Kang R et al (2025) Ciprofloxacin enhances RSL3-induced ferroptosis by promoting mitochondrial Zn2+ accumulation via the STING1\u2013CAV2 pathway. J Biol Chem 301(10):110653. https:\/\/doi.org\/10.1016\/j.jbc.2025.110653","journal-title":"J Biol Chem"},{"issue":"1-3","key":"5960_CR106","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejphar.2009.02.006","volume":"607","author":"W-C Tsai","year":"2009","unstructured":"Tsai W-C, Hsu C-C, Chen H-C, Hsu Y-H, Lin M-S, Wu C-W et al (2009) Ciprofloxacin-mediated inhibition of tenocyte migration and down-regulation of focal adhesion kinase phosphorylation. Eur J Pharmacol 607(1\u20133):23\u201326. https:\/\/doi.org\/10.1016\/j.ejphar.2009.02.006","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"5960_CR107","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3892\/ijmm.2016.2841","volume":"39","author":"K Ueta","year":"2017","unstructured":"Ueta K, Yamamoto J, Tanaka T, Nakano Y, Kitagawa T, Nishizawa S (2017) 5-Aminolevulinic acid enhances mitochondrial stress upon ionizing irradiation exposure and increases delayed production of reactive oxygen species and cell death in glioma cells. Int J Mol Med 39(2):387\u2013398. https:\/\/doi.org\/10.3892\/ijmm.2016.2841","journal-title":"Int J Mol Med"},{"issue":"10","key":"5960_CR108","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185801","volume":"12","author":"G Valianatos","year":"2017","unstructured":"Valianatos G, Valcikova B, Growkova K, Verlande A, Mlcochova J, Radova L et al (2017) A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein. PLoS ONE 12(10):e0185801. https:\/\/doi.org\/10.1371\/journal.pone.0185801","journal-title":"PLoS ONE"},{"issue":"2","key":"5960_CR109","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1053\/j.seminoncol.2022.03.002","volume":"49","author":"RWF van Leeuwen","year":"2022","unstructured":"van Leeuwen RWF, le Comte M, Reyners AKL, van den Tweel A, van Vlijmen B, Kwee W et al (2022) Evidence- and consensus-based guidelines for drug-drug interactions with anticancer drugs; a practical and universal tool for management. Semin Oncol 49(2):119\u2013129. https:\/\/doi.org\/10.1053\/j.seminoncol.2022.03.002","journal-title":"Semin Oncol"},{"issue":"9","key":"5960_CR110","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3390\/antibiotics11091193","volume":"11","author":"B Viaggi","year":"2022","unstructured":"Viaggi B, Cangialosi A, Langer M, Olivieri C, Gori A, Corona A et al (2022) Tissue penetration of antimicrobials in intensive care unit patients: a systematic review-part II. Antibiotics (Basel) 11(9):1193. https:\/\/doi.org\/10.3390\/antibiotics11091193","journal-title":"Antibiotics (Basel)"},{"issue":"4","key":"5960_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.idnow.2025.105062","volume":"55","author":"F Vuotto","year":"2025","unstructured":"Vuotto F, Bru JP, Canoui E, Caseris M, Chopin MCC, Cohen R et al (2025) The latest updates on the proper use of fluoroquinolones - actualisation 2025 update by the SPILF and the GPIP. Infect Dis Now 55(4):105062. https:\/\/doi.org\/10.1016\/j.idnow.2025.105062","journal-title":"Infect Dis Now"},{"issue":"18","key":"5960_CR112","doi-asserted-by":"publisher","first-page":"29760","DOI":"10.18632\/oncotarget.15964","volume":"8","author":"Y Wen","year":"2017","unstructured":"Wen Y, Zhao R-Q, Zhang Y-K, Gupta P, Fu L-X, Tang A-Z et al (2017) Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells. Oncotarget 8(18):29760\u201329770. https:\/\/doi.org\/10.18632\/oncotarget.15964","journal-title":"Oncotarget"},{"issue":"14","key":"5960_CR113","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.3390\/molecules25143138","volume":"25","author":"I Wieleba","year":"2020","unstructured":"Wieleba I, Wojas-Krawczyk K, Krawczyk P (2020) Aptamers in non-small cell lung cancer treatment. Molecules 25(14):3138. https:\/\/doi.org\/10.3390\/molecules25143138","journal-title":"Molecules"},{"key":"5960_CR114","volume-title":"Tobacco cessation: the WHO perspective","author":"CP Wild","year":"2020","unstructured":"Wild CP, Weiderpass E, Stewart BW (2020) Tobacco cessation: the WHO perspective. International Agency for Research on Cancer, Lyon, France"},{"issue":"5","key":"5960_CR115","doi-asserted-by":"publisher","first-page":"942","DOI":"10.2214\/AJR.16.16800","volume":"208","author":"VK Wong","year":"2017","unstructured":"Wong VK, Lubner MG, Menias CO, Mellnick VM, Kennedy TA, Bhalla S et al (2017) Clinical and imaging features of noncutaneous melanoma. Am J Roentgenol 208(5):942\u2013959. https:\/\/doi.org\/10.2214\/AJR.16.16800","journal-title":"Am J Roentgenol"},{"issue":"2","key":"5960_CR116","first-page":"111","volume":"2","author":"X Wu","year":"2014","unstructured":"Wu X, Daniels G, Lee P, Monaco ME (2014) Lipid metabolism in prostate cancer. American Journal of Clinical and Experimental Urology 2(2):111\u2013122","journal-title":"American Journal of Clinical and Experimental Urology"},{"key":"5960_CR117","doi-asserted-by":"publisher","first-page":"1259461","DOI":"10.3389\/fimmu.2023.1259461","volume":"14","author":"Y Wu","year":"2023","unstructured":"Wu Y, Zhuang J, Qu Z, Yang X, Han S (2023) Advances in immunotyping of colorectal cancer. Front Immunol 14:1259461. https:\/\/doi.org\/10.3389\/fimmu.2023.1259461","journal-title":"Front Immunol"},{"issue":"10","key":"5960_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101174","volume":"14","author":"Y Xi","year":"2021","unstructured":"Xi Y, Xu P (2021) Global colorectal cancer burden in 2020 and projections to 2040. Translational Oncology 14(10):101174. https:\/\/doi.org\/10.1016\/j.tranon.2021.101174","journal-title":"Translational Oncology"},{"key":"5960_CR119","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.biopha.2018.12.119","volume":"111","author":"V Yadav","year":"2019","unstructured":"Yadav V, Talwar P (2019) Repositioning of fluoroquinolones from antibiotic to anti-cancer agents: an underestimated truth. Biomed Pharmacother 111:934\u2013946. https:\/\/doi.org\/10.1016\/j.biopha.2018.12.119","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"5960_CR120","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s12885-015-1560-y","volume":"15","author":"V Yadav","year":"2015","unstructured":"Yadav V, Varshney P, Sultana S, Yadav J, Saini N (2015) Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation. BMC Cancer 15(1):581. https:\/\/doi.org\/10.1186\/s12885-015-1560-y","journal-title":"BMC Cancer"},{"issue":"1","key":"5960_CR121","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00554-y","volume":"6","author":"L Yu","year":"2021","unstructured":"Yu L, Liu P (2021) Cytosolic DNA sensing by cGAS: regulation, function, and human diseases. Signal Transduct Target Ther 6(1):170. https:\/\/doi.org\/10.1038\/s41392-021-00554-y","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"5960_CR122","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/biomedicines12040761","volume":"12","author":"R Yudhawati","year":"2024","unstructured":"Yudhawati R, Wicaksono NF (2024) Immunomodulatory effects of fluoroquinolones in community-acquired pneumonia-associated acute respiratory distress syndrome. Biomedicines 12(4):761. https:\/\/doi.org\/10.3390\/biomedicines12040761","journal-title":"Biomedicines"},{"key":"5960_CR123","unstructured":"Zandi A, MOINI ZT, Ziai SA, Khazaei PY, HAJI MHM. The synergistic effects of the combination of ciprofloxacin and temozolomide on human glioblastoma A-172 cell line. Middle East Journal of Cancer. 2017;8(1):31\u20138."},{"issue":"6","key":"5960_CR124","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1039\/d0bm02155e","volume":"9","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, Kng J, Yang C, Hedrick JL, Yang YY (2021) Cationic polymer synergizing with chemotherapeutics and re-purposing antibiotics against cancer cells. Biomater Sci 9(6):2174\u20132182. https:\/\/doi.org\/10.1039\/d0bm02155e","journal-title":"Biomater Sci"},{"issue":"1","key":"5960_CR125","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1538-9","volume":"16","author":"M Zusso","year":"2019","unstructured":"Zusso M, Lunardi V, Franceschini D, Pagetta A, Lo R, Stifani S et al (2019) Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4\/NF-kB pathway. J Neuroinflammation 16(1):148. https:\/\/doi.org\/10.1186\/s12974-019-1538-9","journal-title":"J Neuroinflammation"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05960-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05960-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05960-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:24:12Z","timestamp":1790990652000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05960-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,3]]},"references-count":125,"alternative-id":["5960"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05960-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,3]]},"assertion":[{"value":"27 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}